Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.

Capuron L, Pagnoni G, Drake DF, Woolwine BJ, Spivey JR, Crowe RJ, Votaw JR, Goodman MM, Miller AH.

Arch Gen Psychiatry. 2012 Oct;69(10):1044-53. doi: 10.1001/archgenpsychiatry.2011.2094.

2.

Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.

Felger JC, Miller AH.

Front Neuroendocrinol. 2012 Aug;33(3):315-27. doi: 10.1016/j.yfrne.2012.09.003. Epub 2012 Sep 21. Review.

3.

Involvement of basal ganglia and orbitofrontal cortex in goal-directed behavior.

Hollerman JR, Tremblay L, Schultz W.

Prog Brain Res. 2000;126:193-215. Review.

PMID:
11105648
4.

[Hepatitis C, interferon a and depression: main physiopathologic hypothesis].

Vignau J, Karila L, Costisella O, Canva V.

Encephale. 2005 May-Jun;31(3):349-57. Review. French.

PMID:
16142050
5.

Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications.

Kuriakose R, Stoessl AJ.

Prog Brain Res. 2010;184:177-92. doi: 10.1016/S0079-6123(10)84009-9. Review.

PMID:
20887875
6.

[Functional neuroimaging of addiction].

Takahashi H.

Nihon Rinsho. 2015 Sep;73(9):1473-80. Review. Japanese.

PMID:
26394506
7.

The role of dopamine and dopaminergic pathways in dystonia: insights from neuroimaging.

Karimi M, Perlmutter JS.

Tremor Other Hyperkinet Mov (N Y). 2015 Jan 29;5:280. doi: 10.7916/D8J101XV. eCollection 2015. Review.

8.

The neurobiology of anhedonia and other reward-related deficits.

Der-Avakian A, Markou A.

Trends Neurosci. 2012 Jan;35(1):68-77. doi: 10.1016/j.tins.2011.11.005. Epub 2011 Dec 15. Review.

9.

Fuel not fun: Reinterpreting attenuated brain responses to reward in obesity.

Kroemer NB, Small DM.

Physiol Behav. 2016 Aug 1;162:37-45. doi: 10.1016/j.physbeh.2016.04.020. Epub 2016 Apr 13. Review.

PMID:
27085908
10.

The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders.

Dobryakova E, Genova HM, DeLuca J, Wylie GR.

Front Neurol. 2015 Mar 12;6:52. doi: 10.3389/fneur.2015.00052. eCollection 2015. Review.

Items per page

Supplemental Content

Write to the Help Desk